A detailed history of Benin Management Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Benin Management Corp holds 4,743 shares of EW stock, worth $315,267. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,743
Previous 5,093 6.87%
Holding current value
$315,267
Previous $470,000 33.62%
% of portfolio
0.09%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$59.7 - $93.78 $20,895 - $32,823
-350 Reduced 6.87%
4,743 $312,000
Q2 2024

Jul 23, 2024

BUY
$84.3 - $94.31 $3,624 - $4,055
43 Added 0.85%
5,093 $470,000
Q1 2024

Apr 15, 2024

SELL
$72.54 - $95.56 $435 - $573
-6 Reduced 0.12%
5,050 $482,000
Q4 2023

Jan 25, 2024

SELL
$61.71 - $77.76 $82,938 - $104,509
-1,344 Reduced 21.0%
5,056 $385,000
Q2 2023

Jul 24, 2023

SELL
$81.41 - $94.33 $122,115 - $141,495
-1,500 Reduced 18.99%
6,400 $603,000
Q4 2022

Feb 27, 2023

BUY
$68.3 - $87.44 $368,820 - $472,176
5,400 Added 216.0%
7,900 $589,000
Q2 2022

Aug 03, 2022

BUY
$86.5 - $128.27 $60,550 - $89,789
700 Added 38.89%
2,500 $238,000
Q1 2022

Apr 21, 2022

SELL
$101.96 - $128.34 $285,488 - $359,352
-2,800 Reduced 60.87%
1,800 $212,000
Q3 2021

Oct 25, 2021

SELL
$102.91 - $122.75 $246,984 - $294,600
-2,400 Reduced 34.29%
4,600 $521,000
Q2 2021

Jul 21, 2021

SELL
$83.84 - $104.76 $8,384 - $10,476
-100 Reduced 1.41%
7,000 $725,000
Q1 2021

Apr 27, 2021

BUY
$78.68 - $90.67 $291,116 - $335,479
3,700 Added 108.82%
7,100 $594,000
Q4 2020

Jan 25, 2021

BUY
$71.69 - $91.23 $243,746 - $310,182
3,400 New
3,400 $310,000
Q1 2018

Apr 24, 2018

SELL
$37.19 - $47.45 $197,107 - $251,485
-5,300 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$36.29 - $38.83 $192,337 - $205,799
5,300
5,300 $579,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Benin Management Corp Portfolio

Follow Benin Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.